Lexicon Pharmaceuticals Stock Price

0.05 (2.51%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 815,089
Bid Price 2.00
Ask Price 2.08
News -
Day High 2.075


52 Week Range


Day Low 1.95
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Lexicon Pharmaceuticals Inc LXRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.05 2.51% 2.04 17:10:19
Open Price Low Price High Price Close Price Prev Close
2.00 1.95 2.075 2.03 1.99
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
4,953 815,089 $ 2.00 $ 1,629,376 - 1.31 - 6.3299
Last Trade Time Type Quantity Stock Price Currency
19:59:50 10 $ 2.04 USD


Draw Mode:

Lexicon Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 305.17M 149.59M 72.24M $ 298.00k $ -261.55k -0.61 -3.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 189.63k 2.50%

more financials information »

Lexicon Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical LXRX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.412.08891.401.841,253,3000.6344.68%
1 Month1.682.08891.311.71643,3090.3621.43%
3 Months2.092.741.311.96550,406-0.05-2.39%
6 Months4.294.7191.312.49616,261-2.25-52.45%
1 Year4.786.32991.313.80760,273-2.74-57.32%
3 Years5.949.651.033.861,958,814-3.90-65.66%
5 Years17.9318.001.034.841,434,128-15.89-88.62%

Lexicon Pharmaceuticals Description

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of pharmaceutical products for the treatment of human disease. Some of its drugs candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

Your Recent History
Lexicon Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.